Concepedia

Johanna Dahllund

JD

Statistics

Publications

9

Citations

854

H-Index

9

Active since

1998

Affiliations

Karo Pharma (Sweden)(Current)

University of Turku

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Oulu

Johanna Dahllund is an author at Karo Pharma (Sweden) specializing in estrogen receptors, hormone signaling, and estrogen receptor signaling.

Publications per year

1998–2005

9

Publications

9

Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture

Qiang Qu, M. Perälä-Heape, Anita I. Kapanen et al. · Bone · 1998 · 246 citations

Medicine, Cell Biology, Endocrinology +14

Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells

Anu Kallio, Aiping Zheng, Johanna Dahllund et al. · APOPTOSIS · 2005 · 129 citations

Life Sciences, Cell Biology, Oncology +14

Estren Is a Selective Estrogen Receptor Modulator with Transcriptional Activity

Sofia Movérare, Johanna Dahllund, Niklas Andersson et al. · Molecular Pharmacology · 2003 · 126 citations

Medicine, Endocrinology, Molecular Biology +17

Selective Estrogenic Effects of a Novel Triphenylethylene Compound, FC1271a, on Bone, Cholesterol Level, and Reproductive Tissues in Intact and Ovariectomized Rats<sup>1</sup>

Qiang Qu, Huili Zheng, Johanna Dahllund et al. · Endocrinology · 2000 · 122 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators

Seongkon Kim, Jane Y. Wu, Elizabeth T. Birzin et al. · Journal of Medicinal Chemistry · 2004 · 101 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 9